Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

VOLITIONRX LTD Director's Dealing 2014

Mar 12, 2014

34395_dirs_2014-03-12_3166a0bd-f24e-425b-9659-6d7be26ab401.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: VOLITIONRX LTD (VNRX)
CIK: 0000093314
Period of Report: 2014-03-10

Reporting Person: Innes Guy Archibald (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-03-10 Common Stock P 38884 $45793.28 Acquired 1108103 Indirect
2014-03-10 Common Stock P 3572 $4206.72 Acquired 1111675 Indirect

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-03-10 Warrant $0.5 A 5484 Acquired 2016-06-20 Common Stock (5484) Indirect
2014-03-10 Warrant $2.6 A 1786 Acquired 2016-05-10 Common Stock (1786) Indirect

Footnotes

F1: On December 27, 2013, Guy Archibald Innes entered into a Stock Purchase Agreement with George Stephen Morris, pursuant to which Mr. Innes purchased 38,884 shares of common stock of the Issuer and 5,484 common stock purchase warrants for a total purchase price of $45,793.28. The shares and warrants were issued to Mr. Innes on March 10, 2014.

F2: On December 27, 2013, Guy Archibald Innes entered into a Stock Purchase Agreement with Satu Vainikka, pursuant to which Mr. Innes purchased 3,572 shares of common stock of the Issuer and 1,786 common stock purchase warrants for a total purchase price of $4,206.72. The shares and warrants were issued to Mr. Innes on March 10, 2014.

F3: The foregoing shares and warrants were placed in trust, of which Mr. Innes is the Trustee for the benefit of certain minors.